Cochrane Abstracts
Doxapram versus methylxanthine for apnea in preterm infants: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Doxapram Versus Methylxanthine for Apnea in Preterm Infants: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431272/all/Doxapram_versus_methylxanthine_for_apnea_in_preterm_infants:_Cochrane_systematic_review. Accessed 08 December 2023.
Doxapram versus methylxanthine for apnea in preterm infants: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431272/all/Doxapram_versus_methylxanthine_for_apnea_in_preterm_infants:_Cochrane_systematic_review. Accessed December 8, 2023.
Doxapram versus methylxanthine for apnea in preterm infants: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431272/all/Doxapram_versus_methylxanthine_for_apnea_in_preterm_infants:_Cochrane_systematic_review
Doxapram Versus Methylxanthine for Apnea in Preterm Infants: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431272/all/Doxapram_versus_methylxanthine_for_apnea_in_preterm_infants:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Doxapram versus methylxanthine for apnea in preterm infants: Cochrane systematic review
ID - 431272
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431272/all/Doxapram_versus_methylxanthine_for_apnea_in_preterm_infants:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
